Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexicon Pharmaceuticals (LXRX) Long-Term Debt Issuances (2023)

Lexicon Pharmaceuticals (LXRX) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$1000.0 as the latest value for Q4 2023.

  • Quarterly Long-Term Debt Issuances changed N/A to -$1000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $50.0 million through Sep 2024, changed 0.0% year-over-year, with the annual reading at $50.0 million for FY2023, 2.24% up from the prior year.
  • Long-Term Debt Issuances for Q4 2023 was -$1000.0 at Lexicon Pharmaceuticals, down from $1000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $50.0 million in Q2 2023, with the low at -$1000.0 in Q4 2023.